DexCom Inc
DXCM· Nasdaq
DXCMDexCom Inc
Filed Feb 11, 2021 · 10-K · 42 days after period end · 0001093557-21-000024
derived · Computed from the longer spans the company filed.
| Metric | Q4 2020dderived from reported figures | Q4 2019 | Q4 2018 | Q4 2017 |
|---|---|---|---|---|
| Revenue | $568.90M | $462.80M | $338.00M | $221.00M |
| Net Income | $411.30M | $92.70M | -$179.70M | -$9.40M |
| EPS Diluted | — | $1.00 | -$2.03 | -$0.11 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
DexCom Inc · CIK 1093557 · Engraved from SEC EDGAR
ended Dec 31, 2020 · filed Feb 11, 2021 · 42 d after period end
